Welcome to our dedicated page for Ambase SEC filings (Ticker: ABCP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AmBase Corporation’s financial story is written in the language of litigation—footnotes on courtroom milestones, contingent recoveries, and specialized funding structures that make even veteran analysts pause. If you have ever searched hundreds of pages for a single reference to a settlement or wondered how legal fees impact equity, you know the challenge.
Stock Titan solves that by pairing every disclosure with AI-powered summaries. Need AmBase Corporation insider trading Form 4 transactions before tomorrow’s open? They appear here the moment the filing hits EDGAR, alongside plain-English context. Exploring an AmBase Corporation quarterly earnings report 10-Q filing? Our engine highlights liquidity updates tied to ongoing lawsuits. From AmBase Corporation annual report 10-K simplified breakdowns to instant alerts on AmBase Corporation 8-K material events explained, the platform turns complex documents into actionable insight.
All core forms are covered in real time:
- Form 4: AmBase Corporation Form 4 insider transactions real-time with alerts on executive activity
- 10-Q: detailed cash-flow and segment trends with AmBase Corporation earnings report filing analysis
- 10-K: historical context and risk factors—understanding AmBase Corporation SEC documents with AI
- DEF 14A: AmBase Corporation proxy statement executive compensation made clear
Professionals use these insights to monitor AmBase Corporation executive stock transactions Form 4, gauge litigation progress, and compare quarter-over-quarter funding capacity—all without parsing technical prose. Skip the hunting; the critical data is already surfaced, explained, and ready for decision-making.
AmBase Corporation filed its quarterly report for the period ended September 30, 2025, reporting a net loss of $1.091 million for Q3 and $3.766 million for the nine months. Management states there is substantial doubt about the company’s ability to continue as a going concern based on current cash resources and expected needs.
Cash and cash equivalents were $239,000 at September 30, 2025, against total liabilities of $8.130 million, driven primarily by related‑party loans of $2.0 million (BARC Investments LLC) and $3.2 million (R.A. Bianco). Stockholders’ equity was a deficit of $7.891 million. Q3 operating expenses were $985,000, down from $1.523 million a year ago; interest expense for the nine months was $245,000.
The company continues multiple legal actions related to its former investment in the 111 West 57th Property. The court set a bench trial for November 30, 2026 in two matters, with interim decisions issued on September 9, 2025 and appeal activity continuing. During 2025, AmBase recorded $124,000 of other income from an employee retention credit refund.
AmBase Corporation reported the execution of a Senior Promissory Note in the principal amount of
FAQ
What is the current stock price of Ambase (ABCP)?
What is the market cap of Ambase (ABCP)?
